[Prevention of adverse reactions of antituberculous drugs in pulmonary tuberculosis in patients with different genetic background].

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

[Prevention of adverse reactions of antituberculous drugs in pulmonary tuberculosis in patients with different genetic background].

Problemy tuberkuleza i boleznei legkikh - 1 Jan 2003

Tashpulatova F K

Abstract excerpt

To study genetic predisposition to adverse reactions caused by drugs, 367 patients with pulmonary tuberculosis were examined. As a genetic marker, the phenotype of haptoglobin (Hp) carriage, the type of HINC inactivation, the activity of the enzyme G-6-PDHG were determined. Adverse reactions were noted in 60.2% of the patients. If there was an unfavourable combination of genetic markers, adverse reactions...

Topics

Antitubercular Agents
Genetic Markers
Genotype
Humans
Phytotherapy
Tuberculosis, Pulmonary

Source

Open in PubMed

Identifiers

PMID: 12918234

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics